Medline beats, ups guidance

 

Medline posts Q1 adjusted EPS $0.33 on revenue $7.35B, beating profit and sales expectations, raises 2026 organic growth guidance

• Q1 2026 net sales increased 10.7% to $7.4B, while net income declined 25.8% to $239M
• Raised full-year 2026 organic sales growth guidance range to 8.5%–9.5%.
• Maintained full-year 2026 Adjusted EBITDA outlook while updating organic sales growth guidance.

https://finviz.com/quote?t=MDLN&p=d